MedTrace Logo

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

NCT00216775 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-09-02

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of low-dose interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in patients with chronic hepatitis C.

Conditions

  • Hepatitis C, Chronic

Interventions

DRUG

interferon-alfa-2b and ribavirin

Sponsors & Collaborators

  • Kyoto University

    lead OTHER

Principal Investigators

  • Tsutomu Chiba, M.D., Ph.D · Kyoto University Hospital

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2008-05-31
Completion
2008-05-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00216775 on ClinicalTrials.gov